Avalo Therapeutics AVTX
NASDAQ AVTX
$15.58 +0.50 (+3.32%)
At close: Sep 29, 2026 · 4:00 PM EDT

Avalo Therapeutics (AVTX) Total Current Liabilities (2014 - 2026)

Updated

Avalo Therapeutics' Total Current Liabilities was $21.13 million in Q2 2026, up 128.2% from $9.26 million a year earlier and up 82.2% from the prior quarter.

Analysis

Avalo Therapeutics (AVTX) Total Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Avalo Therapeutics came in at $12.94 million, up 85.9% from FY2024.

  • Total Current Liabilities shows a five-year compound annual growth rate of -3.2% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $6.96 million in FY2024 (+50.7%), $4.62 million in FY2023 (-79.1%), $22.11 million in FY2022 (+11.2%) and $19.89 million in FY2021 (+30.6%).
  • The Q2 2026 figure marks the highest quarterly Total Current Liabilities since Q3 2024.
  • Compared with a year earlier, Total Current Liabilities has increased for three straight quarters, with growth averaging 125.9% over the last eight quarters.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q3 2024 (growth of 910.4%); the worst was Q1 2025 (a decline of 97.4%).
  • Per Business Quant data, AVTX's Total Current Liabilities in the three quarters before Q2 2026 was $11.6 million (Q1 2026), $12.94 million (Q4 2025) and $7.97 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Avalo Therapeutics 657.52 Mn 657.52 Mn - 21.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.13 Mn
Mar 31, 2026 11.60 Mn
Dec 31, 2025 12.94 Mn
Sep 30, 2025 7.97 Mn
Jun 30, 2025 9.26 Mn
Mar 31, 2025 5.62 Mn
Dec 31, 2024 6.96 Mn
Sep 30, 2024 60.67 Mn
Jun 30, 2024 96.40 Mn
Mar 31, 2024 215.70 Mn
Dec 31, 2023 4.62 Mn
Sep 30, 2023 6.01 Mn
Jun 30, 2023 22.45 Mn
Mar 31, 2023 23.25 Mn
Dec 31, 2022 22.11 Mn
Sep 30, 2022 18.15 Mn
Jun 30, 2022 15.40 Mn
Mar 31, 2022 17.89 Mn
Dec 31, 2021 19.89 Mn
Sep 30, 2021 19.04 Mn
API Access

Avalo Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=AVTX&period=max&api_key=YOUR_API_KEY